Why Is Neuromuscular Disease Focused Entrada Therapeutics Shares Trading Lower Today?
Entrada Therapeutics Inc (NASDAQ: TRDA) shares are trading lower after the company announced updates on ENTR-601-44 in
Immix Biopharma Announces FDA Approval Of IND Application For CAR-T NXC-201, Enabling U.S. Patient Dosing
NEXICART-2 to expand studies of NXC-201 in relapsed/refractory AL Amyloidosis to U.S. sites based on IND clearance72 patients previously dosed with NXC-201 ex-U.S.First CAR-T program for light-chain (AL)
FDA Alerting Health Care Providers & Facilities Not To Use Cardinal Health Monoject Syringes With Syringe Pumps & Patient-Controlled Analgesia Pumps; FDA Says You May Continue To Use Covidien Monoject Syringes With Syringe Pumps Or PCA Pumps
https://www.fda.gov/medical-devices/letters-health-care-providers/do-not-use-cardinal-health-monoject-syringes-syringe-pumps-and-pca-pumpsThe U.S. Food and Drug Administration (FDA) is alerting health care providers and
U.S. FDA Approves FoundationOne CDx As A Companion Diagnostic For Astrazeneca’s Truqap In Combination With Faslodex To Identify Patients With HR-Positive, HER2-Negative Advanced Breast Cancer
Foundation Medicine Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to be used as a companion diagnostic for AstraZeneca's Truqap™
Why Is Pharma Giant Bristol-Myers Squibb Stock Trading Lower Today?
Shares of Bristol-Myers Squibb Company (NYSE: BMY) and 2seventy Bio Inc (NASDAQ: TSVT) fell after the companies' efforts to win expanded U.S.
Janssen Submits Supplemental Biologics License Application To U.S. FDA Seeking Approval Of RYBREVANT Plus Chemotherapy For The Treatment Of Patients With EGFR-Mutated Non-Small Cell Lung Cancer Who Progressed On Or After Osimertinib
This submission is supported by data from the Phase 3 MARIPOSA-2 Study featured in a Late-Breaking Presidential Symposium session at the 2023 ESMO Congress and simultaneously published in Annals of
FDA Approves Medtronic’s Hypertension Device Despite Initial Doubts From Adcomm Panel
Friday, the FDA approved Medtronic plc's (NYSE: MDT) Symplicity Spyral renal denervation (RDN) system, also known as the Symplicity blood pressure procedure, for hypertension or
Medtronic Announces FDA Approval Of Minimally Invasive Device To Treat Hypertension
The Symplicity™ blood pressure procedure offers patients a new adjunct approach to lowering blood pressureApproval is the culmination of ten years of clinical research and development of the Medtronic renal
Merck’s Latest Drug For Chronic Cough Faces FDA Pushback
A panel of advisors to the Food and Drug Administration (FDA) reportedly expressed concerns about the efficacy of Merck & Company, Inc.'s (NYSE:
Masimo W1 Medical Watch Receives FDA 510(k) Clearance For Over-The-Counter And Prescription Use
Masimo (NASDAQ:MASI) today announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter (OTC) and prescription use (Rx). Masimo W1 is the first FDA-cleared watch to provide